Delivery Order SPE2DB22D2206-SPE2DB25FFS36

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,387.26 firm fixed-price delivery order is for the supply of Phenobarbital 65 mg/ml vials. The contract has a period of performance through November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PHENOBARBITAL 130 MG/ML VIALML. The contract has a firm fixed price of $4,262.54 and a period of performance through March 28, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a vehicle for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,924.30, is for the delivery of PHENOBARBITAL 65 MG/ML VIALML. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of August 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,776.56 firm fixed-price delivery order covers the supply of 130 mg/mL vials of the drug Phenobarbital. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,075.92, is a Firm Fixed Price Delivery Order for the supply of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Phenobarbital 65 mg/ml vials, a type of anti-seizure medication, with a ceiling value of $1,263.99 and a completion date of January 23, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,353.29, is for the delivery of Phenobarbital 65 mg/ml vial. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.66 firm fixed-price delivery order is for the supply of 4567243104 PHENOBARBITAL 65 MG/ML VIALML, a pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Phenobarbital 130 mg/mL vials. The order has a ceiling value of $1,244.41 and is a firm fixed-price contract with a performance period ending on July 30, 2024. This order is not associated with a set-aside program. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,293.93 firm fixed price delivery order is for the supply of Phenobarbital 130 mg/ml vials, a medication used to treat certain types of seizures. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFS36
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,005.42 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has a period of performance through February 20, 2025 and does not include any set-aside designation, indicating open competition.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/21/25, 9:57 AM